Bayer, Tel Aviv University Test Drugs on 3D-Printed Hearts

The Fellowship  |  July 14, 2020

Last year, we told you about how Israeli researchers at Tel Aviv University discovered how to print a human heart with cells and blood vessels. Now scientists will be able to perform cardiotoxicity screening reports Israel21c:

Human heart tissues 3D-printed in Tel Aviv University Prof. Tal Dvir’s Laboratory for Tissue Engineering and Regenerative Medicine will be used to test the cardiotoxicity of experimental drugs according to a collaboration agreement between the university’s tech-transfer company, Ramot, and pharmaceutical giant Bayer.

“We are excited to start this new collaboration with Tel Aviv University, which will address a new area of early assessment of safety and tolerability of drug candidates,” said Eckhard von Keutz, head of Translational Sciences at Bayer.